The Nkateko trial

Conditions

Hypertension Circulatory System Essential (primary) hypertension

Margaret Thorogood, Jane Goudge, Chodziwadziwa Kabudula, Felix Limbani, Jacqueline Roseleur et al. (6 authors)

PLoS ONE2019-01-105 citations

10.1371/journal.pone.0208983

Task shifting to improve the provision of integrated chronic care: realist evaluation of a lay health worker intervention in rural South Africa

Felix Limbani, Margaret Thorogood, F. Xavier Gómez‐Olivé, Chodziwadziwa Kabudula, Jane Goudge

BMJ Global Health2019-01-0142 citations

10.1136/bmjgh-2018-001084

Can lay health workers support the management of hypertension? Findings of a cluster randomised trial in South Africa

Jane Goudge, Tobias Chirwa, Sandra Eldridge, F. Xavier Gómez‐Olivé, Chodziwadziwa Kabudula et al. (8 authors)

BMJ Global Health2018-02-0144 citations

10.1136/bmjgh-2017-000577

The Nkateko health service trial to improve hypertension management in rural South Africa: study protocol for a randomised controlled trial.

Thorogood M, Goudge J, Bertram M, Chirwa T, Eldridge S, Gómez-Olivé FX, Limbani F, Musenge E, Myakayaka N, Tollman S, Twine R.

2014-11-0717 citations

10.1186/1745-6215-15-435

Interventions

Cluster randomised trial of a complex health services intervention. A cluster is one clinic and the population that it serves. This is a health services research trial and involves th

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Permanent residents of the Agincourt field site aged over 18 years

Exclusion criteria

Exclusion criteria: Pregnancy

Design outcomes

Primary

Measure	Time frame
The primary outcome of the trial is a population-level measure of hypertension control and will be derived from cross-sectional surveys carried out before and after the intervention. This primary outcome will be the change between the two surveys in the percentage of people in the population who have elevated blood pressure that is combined with other factors resulting in a risk profile that indicates moderate or greater added risk of cardiovascular disease.	—

Measure

Time frame

The primary outcome of the trial is a population-level measure of hypertension control and will be derived from cross-sectional surveys carried out before and after the intervention. This primary outcome will be the change between the two surveys in the percentage of people in the population who have elevated blood pressure that is combined with other factors resulting in a risk profile that indicates moderate or greater added risk of cardiovascular disease.

—

Secondary

Measure	Time frame
1. Change in the proportion of the population with undiagnosed hypertension 2. Change in the proportion of the population reporting they had had their blood pressure measured 3. Change in the proportion of the population reporting that they are using medication for hypertension 4. Changes in the proportion of the population at different levels of blood-pressure-related cardiovascular risk by age group and sex 5. Change in the proportion of people in the population reporting that they have attended a clinic in the last year 6. The proportion of people with diagnosed hypertension using primary care clinics who are adherent to prescribed medication, defined by recorded collection of prescriptions 7. Retention in care of people with diagnosed hypertension defined by the proportion of appointments kept during the study period All secondary outcomes will be measured after the intervention has finished.	—

Measure

Time frame

1. Change in the proportion of the population with undiagnosed hypertension 2. Change in the proportion of the population reporting they had had their blood pressure measured 3. Change in the proportion of the population reporting that they are using medication for hypertension 4. Changes in the proportion of the population at different levels of blood-pressure-related cardiovascular risk by age group and sex 5. Change in the proportion of people in the population reporting that they have attended a clinic in the last year 6. The proportion of people with diagnosed hypertension using primary care clinics who are adherent to prescribed medication, defined by recorded collection of prescriptions 7. Retention in care of people with diagnosed hypertension defined by the proportion of appointments kept during the study period All secondary outcomes will be measured after the intervention has finished.

—

Countries

South Africa

Outcome results

None listed